Expression and Function Profiling of Orphan Nuclear Receptors using Bacterial Artificial Chromosome (BAC) Transgenesis
Nuclear Receptor Signaling · 2003
DOI: 10.1621/nrs.01005 ↗At a glance
Journal article in Nuclear Receptor Signaling, 2003. Written by Eric Nemoz-Gaillard and 2 co-authors. Institution: Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA. Cited 1 times so far (Crossref); 9 references. The full text is freely available in PubMed Central.
Abstract (original language)
The long term goal of the Nuclear Receptor Signaling Atlas (NURSA) resides in unraveling the physiological and pathological functions of nuclear receptors (NRs) at the molecular, biochemical and cellular levels. This multi-oriented task requires complementary approaches in order to determine the specific function(s) and precise expression and receptor activity patterns for each individual conventional or orphan receptor. To attain this objective, we have chose to turn to technologies recently made available to engineer bacterial artificial chromosomes (BACs).
Authors and institutions
- Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.
Cite
APA
Nemoz-Gaillard, E., Tsai, M. J., & Tsai, S. Y. (2003). Expression and Function Profiling of Orphan Nuclear Receptors using Bacterial Artificial Chromosome (BAC) Transgenesis. Nuclear Receptor Signaling. https://doi.org/10.1621/nrs.01005
Vancouver
Nemoz-Gaillard E, Tsai MJ, Tsai SY. Expression and Function Profiling of Orphan Nuclear Receptors using Bacterial Artificial Chromosome (BAC) Transgenesis. Nuclear Receptor Signaling. 2003. doi:10.1621/nrs.01005
BibTeX
@article{NemozGaillard2003,
author = {Nemoz-Gaillard, Eric and Tsai, Ming-Jer and Tsai, Sophia Y},
title = {Expression and Function Profiling of Orphan Nuclear Receptors using Bacterial Artificial Chromosome (BAC) Transgenesis},
journal = {Nuclear Receptor Signaling},
year = {2003},
doi = {10.1621/nrs.01005}
}
EUVIMED